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In the mouse, the process of implantation is initiated by the attachment reaction between the blastocyst trophectoderm
and uterine luminal epithelium that occurs at 2200±2300 h on day 4 (day 1  vaginal plug) of pregnancy. Several members
of the EGF family are considered important in embryo±uterine interactions during implantation. This investigation demon-
strates that the expression of two additions to the family, betacellulin and epiregulin, are exquisitely restricted to the
mouse uterine luminal epithelium and underlying stroma adjacent to the implanting blastocyst. These genes are not
expressed during progesterone-maintained delayed implantation, but are rapidly switched on in the uterus surrounding the
implanting blastocyst following termination of the delay by estrogen. These results provide evidence that expression of
betacellulin and epiregulin in the uterus requires the presence of an active blastocyst and suggest an involvement of these
growth factors in the process of implantation. q 1997 Academic Press
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INTRODUCTION and Schlafke, 1967) and is considered to be one of the earli-
est prerequisite events in the implantation process (Psy-
choyos, 1973). In the mouse, the attachment reaction occursThe synchronized development of the preimplantation
in the evening (2200±2300 hr) of day 4 of pregnancy and isembryo to the blastocyst stage, its escape from the zona
preceded by uterine luminal closure which in turn resultspellucida, and differentiation of the uterus to the receptive
in an intimate apposition of the trophectoderm with thestate are all essential to the process of implantation (Psy-
luminal epithelium (Das et al., 1994a; Enders and Schlafke,choyos, 1973; Paria et al., 1993a). The establishment of a
1967; Enders, 1976; Psychoyos, 1973). The attachment reac-differentiated uterus for supporting embryo development
tion is followed by localized stromal decidualization andand implantation is primarily dependent on the coordinated
luminal epithelial apoptosis at the sites of blastocyst im-effects of estrogen and progesterone (Psychoyos, 1973; Paria
plantation (Parr et al., 1987). This results in subsequentet al., 1993a). In the rodent, the ®rst conspicuous sign that
adherence and penetration by trophoblast cells through thethe implantation process has been initiated is an increased
underlying basement membrane (Enders and Schlafke,endometrial vascular permeability at the sites of blastocyst.
1967). Invasion of trophoblast cells continues through theThis can be visualized as discrete blue bands along the
stroma in a regulated manner by the remodeling of the ex-uterus after an intravenous injection of a blue dye solution
tracellular matrix. Several developmentally important and(Psychoyos, 1973; Huet and Dey 1987; Paria et al., 1993a).
estrogen/progesterone-regulated growth factors and their re-This increased localized vascular permeability coincides
ceptor genes are expressed in a temporal and spatial mannerwith the initial attachment reaction between the uterine
during the periimplantation period (reviewed in Das et al.,luminal epithelium and blastocyst trophectoderm (Enders
1994a, 1995).
The uterus is composed of heterogeneous cell types which
respond uniquely to estrogen and progesterone. In the adult1 To whom reprint requests may be addressed.
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mouse uterus, estrogen stimulates proliferation and differ- kinase activity (Heldin, 1995; Prigent and Lemoine, 1992;
Peles and Yarden, 1993). In general, EGF, TGF-a, HB-EGF,entiation of luminal and glandular epithelia, whereas in the
stroma, these processes require both progesterone and estro- AR, betacellulin, epiregulin, and heregulins/NDF can inter-
act with erbB family members via homodimerization or het-gen (Huet-Hudson et al., 1989). A similar steroid hormonal
regulation occurs in the mouse uterus during early preg- erodimerization (Riese et al., 1996; Lim et al., 1997; Elenius
et al., 1997). Thus, cross-talk between the receptor subtypesnancy. Preovulatory ovarian estrogen directs epithelial cell
proliferation on days 1 and 2, whereas on day 3 progesterone with various ligands can serve as a potential signaling mech-
anism (Earp et al., 1995; Hynes and Stern, 1994).from newly formed corpora lutea initiates stromal cell pro-
liferation that is further stimulated by preimplantation es- The expression patterns of EGF, TGF-a, AR, and HB-EGF
in the mouse uterus during the periimplantation period andtrogen secretion early on day 4. During implantation, stro-
mal cells undergo extensive proliferation and differentiation their responsiveness to sex steroid hormones have been ex-
amined (reviewed in Das et al., 1994a, , 1995). Overall, theinto decidual cells (Huet-Hudson et al., 1989).
The attachment reaction culminates from an intimate results suggest that in the mouse EGF is not expressed in
the periimplantation uterus, while AR is expressed in a P4-``cross-talk'' between the trophectoderm of the blastocyst
and luminal epithelium of the receptive uterus. In the dependent manner on day 4 (the day of implantation) and
the expression of HB-EGF in the uterus at the sites of blasto-mouse, uterine receptivity occurs only for a limited period
during pregnancy or pseudopregnancy. In pregnant or pseu- cyst apposition several hours prior to the attachment reac-
tion is dependent upon the presence of active blastocysts.dopregnant mice, the prereceptive uterus on day 3 becomes
receptive on day 4 (the day of implantation), while by day Although TGF-a is expressed in the mouse uterus during
the periimplantation period (Tamada et al., 1991), the role5 (as examined by blastocyst transfers) the uterus becomes
refractory and fails to initiate implantation (Paria et al., of TGF-a in implantation is questioned since female mice
de®cient in TGF-a are apparently fertile (Bruce-Mann et al.,1993a). In this species, ovariectomy in the morning of day
4 of pregnancy prior to preimplantation of ovarian estrogen 1993; Luetteke et al., 1993). However, it is not yet known
whether this is due to the overlapping expression and/orsecretion results in blastocyst dormancy and failure in at-
tachment reaction, a condition termed delayed implanta- compensation of TGF-a by other members. Therefore, infor-
mation regarding the overlapping and distinctive expressiontion. Delayed implantation can be maintained by continued
progesterone treatment, but is terminated by an injection of these growth factors in the uterus is required to under-
stand their roles in uterine biology and implantation. Inof estrogen with blastocyst activation and initiation of im-
plantation (attachment reaction) (Huet and Dey, 1987; Yos- this respect, the expression of betacellulin, epiregulin, and
heregulins in the periimplantation uterus has not been ex-hinaga and Adams, 1966). The luminal closure and apposi-
tion occur during the progesterone-treated delayed implan- amined. This information is especially important for inves-
tigators who are engaged in making null mice for thesetation, but the attachment reaction (uterine blue reaction)
and the subsequent events do not occur unless estrogen growth factors to address their importance in development
and reproduction.treatment is provided (Psychoyos, 1973; Nilsson, 1974; En-
ders, 1976). In this investigation, we examined the cell-speci®c ``win-
dow'' of expression of betacellulin and epiregulin in theThe regulated expression of several growth factors and
their receptors in the uterus and embryo during the periim- periimplantation mouse uterus. Betacellulin was ®rst iden-
ti®ed from mouse pancreatic b-cell tumors and is a 32-kDaplantation period or under steroid hormonal stimulation
suggests that polypeptide growth factors could serve as local glycoprotein (Shing et al., 1993). Betacellulin is a potent
mitogen for retinal pigment epithelial cells and vascularmediators of steroid hormone actions (reviewed in Das et
al., 1994a, 1995). In this respect, the roles of speci®c mem- smooth muscle cells. Epiregulin was originally puri®ed
from conditioned medium of a mouse ®broblast-derived tu-bers of the epidermal growth factor (EGF) family of growth
factors in uterine biology and implantation have been stud- mor cell line and is a 5.4-kDa protein with no potential N-
linked glycosylation sites (Toyoda et al., 1995a). The matureied more extensively than other members or other polypep-
tide growth factors (reviewed in Das et al., 1994a, 1995). forms of betacellulin and epiregulin contain the six con-
served cysteine residues that are arranged in a characteristicThe EGF family includes EGF, transforming growth factor-
a (TGF-a), heparin-binding EGF (HB-EGF), amphiregulin pattern common to all members of the EGF family. The
expression of betacellulin in the BTC-3 mouse insulinoma(AR), betacellulin, epiregulin, and heregulins/neu differenti-
ation factors (NDFs) (Cohen, 1963; Derynck et al., 1984; cell line (Shing et al., 1993) and the MCF-7 human breast
adenocarcinoma cell line (Sasada et al., 1993) implies thatHigashiyama et al., 1991; Holmes et al. 1992; Shoyab et al.,
1988; Shing et al., 1993; Toyoda et al., 1995a). They are it may play a role in tumorigenesis. However, betacellulin
is widely expressed in normal mouse tissues (Shing et al.,synthesized as transmembrane proteins that are proteolyti-
cally processed to release the mature forms (Massague and 1993) suggesting the involvement of this growth factor in
normal cell functions. Betacellulin can act as a ligand forPandiella, 1993). In the rodent, these ligands can interact
with the receptor subtypes of the erbB gene family. This EGF-R/ErbB1 and erbB-4 (Riese et al., 1996). Epiregulin ex-
hibits bifunctional regulatory functions; it can either in-family is composed of four receptor tyrosine kinases: ErbB1
(EGF-R), ErbB2, ErbB3, and ErbB4. They share a common hibit the growth of several epithelial tumor cells or stimu-
late the growth of ®broblast and other cell types. The bind-structural feature, but differ in their ligand speci®city and
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SP6 polymerases. A part of the ribosomal protein L-7 (rpL7) cDNAing of epiregulin to EGF-R/ErbB1 of A431 cells is weaker
(246 bp, nt 359±604; GenBank Accession No. M29016) was sub-than that of EGF, but is more potent than EGF as a mitogen
cloned into pCR-Script vector and used as a template for synthesisfor hepatocytes and ®broblasts (Toyoda et al., 1995a). It is
of 32P-labeled antisense rpL7 RNA probe with T7 polymerase. Thenot known whether epiregulin can bind to other receptor
probes had speci®c activities of 2 1 109 dpm/mg.subtypes of the EGF family. Previously, epiregulin was re-
ported to be expressed exclusively in day 7 mouse embryos,
but not in various other tissues (Toyoda et al., 1995b). How- RT-PCR Analysis
ever, the present investigation demonstrates that both beta-
Speci®c oligonucleotide primers were designed for RT-PCR anal-cellulin and epiregulin are expressed in the uterus exclu-
ysis of betacellulin (Shing et al., 1993) and house-keeping gene rpL7sively at the sites of blastocyst apposition at the time of
(Meyuhas and Kelin, 1990). The sense and antisense primers forattachment reaction (day 4) and during the initial phase of
betacellulin were 5*-CCAACAGCCCCGGGTAGCAG-3* (nt 119±
implantation (day 5). 138) and 5*-GACAGCAGGTGCAGACGCCG-3* (nt 520±539), re-
spectively. The sense and antisense primers for rpL7 were 5*-TCA-
ATGGAGTAAGCCCAAAG-3* (nt 359±378) and 5*-CAAGAG-
MATERIALS AND METHODS ACCGAGCAATCAAG-3* (nt 585±604), respectively. The internal
oligonucleotides, 5*-CACAGGTACCACCCCTAGAC-3* (nt 571±
590, sense) and 5*-GATTGCCTTGACAGATAATTC-3* (nt 564±Animals and Tissue Preparation
584, sense), were used for Southern hybridization of RT-PCR-am-
CD-1 mice (Charles River Laboratories, Raleigh, NC) were pli®ed products for betacellulin and rpL7, respectively. The proto-
housed in the animal care facility at the University of Kansas Medi- cols for RT reaction, PCR ampli®cation, and Southern hybridiza-
cal Center in accordance with NIH Standards for the Care and Use tion were as described previously (Paria et al., 1993b).
of Experimental Animals. Adult females were mated with fertile
males of the same strain to induce pregnancy (day 1 vaginal plug).
Mice on days 1±8 were killed at 0900 hr and their uteri were col- Northern Blot Hybridization
lected for RNA preparation and in situ hybridization. Pregnancy
Total RNA was extracted from tissues by a modi®ed guanidineon days 1±4 was con®rmed by recovering embryos from the repro-
thiocyanate procedure (Das et al., 1994b; Han et al., 1987). Poly(A)/ductive tracts. On the evening of day 4 (2300 hr) at the time of
RNA samples were isolated by oligo(dT)±cellulose column chroma-attachment reaction or on days 5±6, implantation sites were identi-
tography (Sambrook et al., 1989). Poly(A)/ RNA samples (2.0 mg)®ed by monitoring the localized uterine vascular permeability at
were denatured, separated by formaldehyde±agarose gel electropho-the sites of blastocysts after intravenous injection of Chicago blue
resis, and transferred and cross-linked to nylon membranes by UVB solution in saline. Implantation sites were demarcated by discrete
irradiation. Northern blots were prehybridized and hybridized asblue bands along the uterus (Paria et al., 1993a). On days 7 and 8,
described previously (Das et al., 1994a, 1995). Brie¯y, hybridizationimplantation sites are distinct and their identi®cation does not
was carried out for 20 hr at 687C in 31 SET (11 SET 150 mMrequire any special manipulation. To induce and maintain delayed
NaCl, 5 mM EDTA, and 10 mM Tris±HCl, pH 8.0), 20 mM phos-implantation, mice were ovariectomized in the morning (0800±
phate buffer (pH 7.2), 250 mg/ml tRNA, 10% dextran sulfate, and 0900 hr) of day 4 of pregnancy and received daily injections of
2 1 106 counts/min of 32P-labeled antisense RNA probe/ml of theprogesterone (P4, 2 mg/mouse) from day 5 to 7 (Paria et al., 1993b;
hybridization buffer. After hybridization, the blots were washed onceYoshinaga and Adams, 1966). To terminate delayed implantation
in 11 SSC, 0.1% SDS for 1 hr at 687C followed by a second washingand to induce blastocyst activation, the P4-primed delayed im-
in 0.31 SSC, 0.1% SDS for 1 hr under the same conditions, and theplanting mice were given an injection of estradiol-17b (E2, 25 ng/
hybrids were detected by autoradiography. Stripping of the hybrid-mice) on the third day of the delay (day 7). Mice were killed 24 hr
ized probe before subsequent rehybridization was achieved as de-after treatment with the respective steroid hormones and their uteri
scribed previously (Das et al., 1995). Each blot was ®rst hybridizedwere collected for in situ hybridization. The ®rst visually detect-
to the betacellulin or epiregulin probe and then to the rpL7 probeable implantation sites after blue dye injection normally become
to con®rm integrity, equal loading, and blotting of RNA samples.evident 18±24 hr after an E2 injection.
In Situ HybridizationHybridization Probes
Using a mouse betacellulin cDNA (1179 bp) clone (GenBank Ac- In situ hybridization was performed as described previously (Das
et al., 1994a; Lim et al., 1997). Frozen uterine sections (10 mm)cession No. L08394) as a template (Shing et al., 1993), a 350-bp
fragment (nt 176±525) from the coding region of the gene was sub- were mounted onto poly-L-lysine-coated slides and stored at 0707C
until used. When required, frozen sections were cut serially to de-cloned into the pGEM7Zf(/) vector. A 492-bp fragment of murine
epiregulin (GenBank Accession No. D30782, nt 139±630) was ampli- tect the sites of blastocysts. After removal from 0707C, the slides
with the uterine sections were placed on a slide warmer (377C) for®ed by RT-PCR from murine day 7 implantation site RNA and
inserted into the plasmid vector pCR2.1 (Invitrogen, Carlsbad, CA). 2 min and then ®xed in 4% paraformaldehyde in PBS for 15 min
at 47C. Following prehybridization, uterine sections were hybrid-Two clones were isolated containing the 492-bp epiregulin insert in
either sense (epi 10) or antisense (epi 12) orientation when linearized ized to 35S-labeled antisense betacellulin or epiregulin cRNA probe
for 4 hr at 457C. As negative controls, uterine sections were hybrid-with SpeI. The authenticity of the clones was determined by se-
quence analysis. For Northern hybridization, 32P-labeled antisense ized with the 35S-labeled sense betacellulin or epiregulin probe.
After hybridization and washing, the slides were incubated withRNA probes for betacellulin and epiregulin were generated using
SP6 and T7 RNA polymerases. For in situ hybridization, sense and RNase-A (20 mg/ml) at 377C for 20 min. RNase-A-resistant hybrids
were detected within 2 weeks of autoradiography using Kodakantisense 35S-labeled RNA probes were generated using T7 and/or
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luminal epithelium (data not shown). Furthermore, no uter-
ine cell-speci®c signals were present at 0900 hr (Figs. 3a
and 3b), 1500 or 1900 hr (data not shown) on day 4 of preg-
nancy. In contrast, distinct signals for betacellulin mRNA
were ®rst detected in the luminal epithelium and underly-
ing stroma at the sites of blastocyst apposition at the time
(2300 hr) of attachment reaction on day 4 (Figs. 3c and 3d).
On the morning of day 5 (0900 hr), an increased number of
luminal epithelial and stromal cells at the sites of implanta-
FIG. 1. RT-PCR analysis of betacellulin mRNA in the mouse
tion exhibited distinct autoradiographic signals (Figs. 3e anduterus. RT-PCR ampli®ed products of betacellulin (421 bp) and
3f). No cell-speci®c signals were detected between the sitesrpL7 (246 bp) were analyzed by agarose gel electrophoresis and
of blastocyst apposition during these times. On day 6, noSouthern blot hybridization with 32P-end-labeled mouse-speci®c
uterine signals were present at the implantation sites (Figs.internal oligos to betacellulin and rpL7, respectively. Lane 1, primer
4a and 4b). However, with progression of the decidualiza-control; lane 2, day 4 pregnant mouse uterus (1800 hr); lane 3,
implantation site on day 4 (2300 hr); and lane 4, mouse lung as a tion process on days 7 and 8, autoradiographic signals were
positive control. detected only in a subpopulation of cells in the decidual
bed at the mesometrial pole of the implantation site (Figs.
4c±4f).
The expression of the epiregulin gene was mostly similar
NTB-2 liquid emulsion. The slides were poststained with hematox- to that of betacellulin. Thus, accumulation of epiregulin
ylin and eosin. mRNA was ®rst detected in the luminal epithelium and
underlying stroma surrounding a blastocyst at the time of
attachment reaction on day 4 of pregnancy and this accumu-
RESULTS lation persisted through the morning of day 5 (Figs. 5a±5f).
On day 6, the signals were markedly reduced at the implanta-
Northern Blot and RT-PCR Analyses of tion sites and were restricted to a small population of stromal
Betacellulin and Epiregulin mRNAs in the cells just underneath the luminal epithelium at the mesome-
Periimplantation Mouse Uterus trial pole (Figs. 6a and 6b). On day 7, epiregulin mRNA accu-
mulated in a number of cells at the primary decidual zoneAs reported previously (Shing et al., 1993), Northern blot
surrounding the implantation chamber (Figs. 6c and 6d). Onhybridization detected several transcripts of betacellulin
day 8, a precipitous decline was noted and the expressionmRNA (4.2, 3.0, and 1.2 kb) in whole uterine poly(A)/
was restricted to only a few cells at the mesometrial poleRNA samples. The levels of these transcripts were low and
(Figs. 6e and 6f). Betacellulin or epiregulin expression wasthey did not show much variation with respect to those
not detected in implanting blastocysts. No positive signalsof rpL7 (a house-keeping gene) during the periimplantation
were detected with the sense cRNA probe for betacellulinperiod (data not shown). RT-PCR also detected the presence
or epiregulin in any uterine or blastocyst sections (data notof betacellulin mRNA in RNA samples of whole uteri at
shown).1800 hr and of implantation sites at 2400 hr on day 4 of
pregnancy. The mouse lung RNA was used as a positive
control (Fig. 1). Northern blot hybridization detected a 4.8-
kb transcript of epiregulin mRNA in whole uterine poly(A)/
RNA samples primarily on day 7 of pregnancy, although
low levels of signals were detected in day 6 and 8 pregnant
uterine samples (Fig. 2).
In Situ Hybridization of Betacellulin and
Epiregulin mRNAs in the Periimplantation
Mouse Uterus
The results of RT-PCR and Northern blot hybridization
of whole uterine RNA samples suggested that the betacel-
lulin and epiregulin genes are expressed in the periimplanta-
tion mouse uterus. However, if expression of these genes is
FIG. 2. Northern blot hybridization of epiregulin mRNA in theimportant for implantation, they should exhibit cell-spe-
periimplantation mouse uterus. Poly(A)/ RNA (2 mg) was separated
ci®c expression in the uterus in a temporal manner. Thus, by agarose±formaldehyde gel electrophoresis, transferred and UV
the distribution of betacellulin and epiregulin mRNAs in cross-linked to nylon membrane, and hybridized sequentially to
the periimplantation uterus was examined by in situ hybrid- 32P-labeled epiregulin and rpL7 antisense cRNA probes. Days of
ization. On days 1±3 of pregnancy, very low levels of autora- pregnancy (days 1±8) are indicated. Autoradiographic exposures
were 2 days for epiregulin and 2 hr for rpL7.diographic signals of betacellulin mRNA were noted in the
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FIG. 3. In situ hybridization of betacellulin mRNA in day 4 and 5 pregnant mouse uteri. Bright®eld and dark®eld photomicrographs of
representative longitudinal sections of uteri at 0900 hr (a, b) and 2300 hr (c, d) on day 4 and at 0900 hr on day 5 (e, f) are shown at 1001.
bl, blastocyst; le, luminal epithelium; ge, glandular epithelium; s, stroma.
In Situ Hybridization of Betacellulin and an active blastocyst, in situ hybridization was carried out
Epiregulin mRNAs in the Delayed Implanting on uterine sections obtained from P4-treated delayed im-
Mouse Uterus planting mice or after the initiation of blastocyst activation
and implantation by an E2 injection. No hybridization sig-To examine whether the expression of the betacellulin
and epiregulin genes in the uterus requires the presence of nals for either betacellulin (Figs. 7a and 7b) or epiregulin
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FIG. 4. In situ hybridization of betacellulin mRNA in day 6±8 pregnant mouse uteri. Bright®eld and dark®eld photomicrographs of
representative cross-sections of uteri at 0900 hr on days 6 (a, b), 7 (c, d), and 8 (e, f) are shown at 401. le, luminal epithelium; em, embryo;
pdz, primary decidual zone; sdz, secondary decidual zone; M, mesometrial pole; AM, antimesometrial pole.
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FIG. 5. In situ hybridization of epiregulin mRNA in day 4 and 5 pregnant mouse uteri. Bright®eld and dark®eld photomicrographs of
representative longitudinal sections of uteri at 1800 hr (a, b) and 2300 hr (c, d) on day 4 and at 0900 hr on day 5 (e, f) are shown at 1001.
bl, blastocyst; le, luminal epithelium; ge, glandular epithelium; s, stroma.
(Figs. 7e and 7f) were detected in luminal epithelial or stro- tion at 24 hr after an E2 injection, the expression of betacel-
lulin (Figs. 7c and 7d) and epiregulin (Figs. 7g and 7h)mal cells surrounding dormant blastocysts that had been in
close apposition with the luminal epithelial cells during P4 mRNAs became distinctly evident in the luminal epithelial
and stromal cells surrounding the implanting blastocysts.treatment. In contrast, with the E2-induced termination of
the delayed implantation and onset of the blastocyst activa- It should be recalled that the attachment reaction (blue reac-
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FIG. 6. In situ hybridization of epiregulin mRNA in day 6±8 pregnant mouse uteri. Bright®eld and dark®eld photomicrographs of
representative cross-sections of uteri at 0900 hr on days 6 (a, b), 7 (c, d), and 8 (e, f) are shown at 401. em, embryo; le, luminal epithelium;
pdz, primary decidual zone; sdz, secondary decidual zone; M, mesometrial pole; AM, antimesometrial pole.
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FIG. 7. In situ hybridization of betacellulin and epiregulin mRNAs in uteri from P4-treated delayed implanting mice before and after an
E2 injection. Bright- and dark®eld photomicrographs of longitudinal uterine sections are shown at 1001. Representative sections from P4-
treated delayed implanting mice hybridized with betacellulin (a, b) or epiregulin (e, f) probes. Representative sections from P4-treated
delayed implanting mice after an E2 injection showing signals for betacellulin mRNA (c, d) or epiregulin mRNA (g, h). bl, blastocyst; le,
luminal epithelium; ge, glandular epithelium; s, stroma.
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FIG. 8. A schematic diagram depicting the distinctive and overlapping expression of HB-EGF, AR, betacellulin (BTC), epiregulin (EPI),
TGF-a, and EGF in the periimplantation (days 1±8 of pregnancy) mouse uterus. This illustration is based on our present and previous in
situ hybridization results. Note overlapping expression of HB-EGF, AR, BTC, EPI, and TGF-a around the time of implantation.
tion) occurs at 18±24 hr after E2 injection in P4-treated de- ment reaction which persists through the attachment reac-
layed implanting mice. Thus, the temporal and cell-speci®c tion and thereafter (Das et al., 1994a). Based on our previous
patterns of the betacellulin and epiregulin gene expressions (Huet-Hudson et al., 1990; Tamada et al., 1991, Paria et al.,
observed in these experiments followed those observed dur- 1994; Das et al., 1994a, 1995) and present results of in situ
ing normal implantation as described above. hybridization, a schematic representation of distinctive and
overlapping expression of the EGF-like ligands is shown in
Fig. 8. Although there are differences in the temporal and
cell-speci®c expression of these growth factors prior to theDISCUSSION
attachment reaction and during the postimplantation pe-
riod, one striking feature is the overlapping expression ofThe present investigation demonstrates that during early
the members in the mouse uterus surrounding the blasto-pregnancy in the mouse the betacellulin and epiregulin
cyst at the time of implantation as outline in Fig. 9. Thisgenes are uniquely expressed in the uterus at the sites of
overlapping cell-speci®c expression during this critical timeblastocyst apposition at the time of the attachment reaction
of embryo±uterine interactions suggests that these growthon day 4 and this expression only persists through the morn-
factors are important for the initiation and succession ofing of day 5. This window of expression of betacellulin or
the attachment reaction. However, distinct spatiotemporalepiregulin is in contrast to the uterine expression pattern
expression of these growth factors before the attachmentof AR or HB-EGF. For example, AR expression occurs
reaction and during the postimplantation period suggeststhroughout the uterine epithelium for most of the day 4 of
that these growth factors have also speci®c functions associ-pregnancy. However, with the onset of blastocyst attach-
ated with the preparation of the uterus for implantation andment reaction late on day 4, AR expression becomes re-
subsequent decidualization processes.stricted in the luminal epithelium at the sites of blastocyst
The EGF-like ligands can interact with members of theapposition followed by its downregulation by the morning
ErbB family via either homodimerization or heterodimeri-of day 5 (Das et al., 1995). In contrast, the HB-EGF gene
zation resulting in signal transduction for various biologicalis expressed exclusively in the uterine luminal epithelium
surrounding the blastocyst several hours prior to the attach- responses. Since the process of implantation involves a
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FIG. 9. A schematic diagram depicting the sites of expression of amphiregulin, HB-EGF, betacellulin, and epiregulin in the mouse uterus
at the time of attachment reaction (2200±2300 hr) on day 4 of pregnancy. This illustration is based on our present and previous in situ
hybridization results. Note that amphiregulin and HB-EGF are expressed in the luminal epithelium, while betacellulin and epiregulin are
expressed in both the luminal epithelium and stroma at the sites of blastocyst apposition. bl, blastocyst; le, luminal epithelium; ge,
glandular epithelium, s, stroma.
``two-way'' cell±cell interaction between the blastocyst and also participate in localized interactions involving blasto-
cyst, epithelium, and stroma at the time of attachment reac-the uterus, ligand±receptor signaling with these growth fac-
tors may participate in preparing both the uterus and the tion. In this respect, betacellulin has been shown to phos-
phorylate uterine ErbB2 obtained from day 5 pregnant miceblastocyst for this interaction and/or they could be integral
components of this interaction. For example, based on its (Lim et al., 1997).
The expression of epiregulin mRNA in the uterus as ob-temporal expression and phosphorylation of EGF-R/ErbB1
in the uterus, AR has been proposed to be involved in the served in the present investigation appears to be speci®cally
unique, since this mRNA was undetectable in many adultpreparation of the uterus for implantation (Das et al., 1995).
The presence of EGF-R/ErbB1 (Das et al., 1994b; Tong et tissues, such as the heart, brain, spleen, lung, liver, skeletal
muscle, kidney, and testes (Toyoda et al., 1995b). Further,al., 1996), ErbB2 (Lim et al., 1997), and ErbB4 (unpublished)
in the uterus is consistent with this proposal. In contrast, our results of epiregulin expression in the uterus are in sharp
contrast to an earlier report that failed to detect epiregulinluminal epithelial HB-EGF via its interaction with heparan
sulfate proteoglycan and EGF-R/ErbB1 on the blastocyst cell mRNA in the periimplantation mouse uterus except in day
7 embryos (Toyoda et al., 1995b). The dilution effect re-surface has been considered to be responsible for adhesion
of the trophectoderm with luminal epithelium during the sulting from the use of whole uterine RNA samples for
Northern blot hybridization and decidual cells contaminat-attachment reaction (Das et al., 1994a; Raab et al., 1996).
Our preliminary observation indicates also the presence of ing day 7 embryo preparations probably contributed to the
reported observation. In fact, the pattern of epiregulinErbB2 and ErbB4 in the blastocyst (unpublished). Thus, the
expression of betacellulin and epiregulin in the luminal epi- mRNA expression as detected by Northern blot hybridiza-
tion of whole uterine RNA samples in our present investiga-thelium and underlying stroma at the sites of blastocyst
apposition suggests that these uterine growth factors could tion is similar to that reported earlier (Toyoda et al., 1995b).
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curly whiskers and often develop corneal in¯ammation. Cell 73,However, our in situ hybridization experiments clearly es-
249±261.tablish that this gene is primarily expressed in the uterus,
Cohen, S. (1962). Isolation of a mouse submaxillary gland proteinnot the embryo, in a temporal and cell-speci®c manner dur-
accelerating incisor eruption and eyelid opening in the mouseing early pregnancy. The signi®cance of the expression of
newborn. J. Biol. Chem. 237, 1555±1562.this gene in a subpopulation of primary decidual cells spe-
Das, S. K., Wang, X-N., Paria, B. C., Damm, D., Abraham, J. A.,
ci®cally on day 7 preceded and followed by its downregula- Klagsbrun, M., Andrews, G. K., and Dey, S. K. (1994a). Heparin-
tion on day 6 and day 8 is not clearly understood. binding EGF-like growth factor gene is induced in the mouse
The expression of betacellulin and epiregulin in the uterus temporally by the blastocyst solely at the site of its apposi-
uterus at the time of implantation, as with HB-EGF (Das et tion: A possible ligand for interaction with blastocyst EGF-recep-
al., 1994a; Raab et al., 1996), is induced by the presence of tor in implantation. Development 120, 1071±1083.
Das, S. K., Tsukamura, H., Paria, B. C., Andrews, G. K., and Dey,active blastocysts, since these genes are not expressed in
S. K. (1994b). Differential expression of epidermal growth factorthe uterus at the sites of blastocyst apposition during the
receptor (EGF-R) gene and regulation of EGF-R bioactivity byP4-maintained delayed implantation or in interimplantation
progesterone and estrogen in the adult mouse uterus. Endocrinol-sites after E2 injection, but they are rapidly expressed at the
ogy 134, 971±981.sites of blastocyst apposition by the termination of the delay
Das, S. K., Chakraborty, I., Paria, B. C., Wang, X-N., Plowman,by E2. In contrast, the expression of the AR gene in the G. D., and Dey, S. K. (1995). Amphiregulin is an implantation-
uterus is primarily regulated by P4 (Das et al., 1995) and speci®c and progesterone-regulated gene in the mouse uterus.
localized expression of this gene in the uterus at the sites Mol. Endocrinol. 9, 691±705.
of blastocyst apposition persists during P4-treated delayed Derynck, R., Roberts, A. B., Winkler, M. E., Chen, Y. E., and Goed-
implantation (unpublished). The nature of the signal(s) ema- del, D. V. (1984). Human transforming growth factor-alpha: Pre-
nating from the active blastocysts that induces these growth cursor structure and expression in E. coli. Cell 38, 287±297.
Earp, H. S., Dawson, T. L., Li, X., and Yu, H. (1995). Heterodimeri-factors locally in the uterus at the sites of implantation
zation and functional interaction between EGF receptor familystill remains unde®ned. Taken together, our present and
members: A new signaling paradigm with implications for breastprevious results suggest that the EGF family of growth fac-
cancer research. Breast Cancer Res. Treat. 35, 115±132.tors and their receptors are important for the process of
Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. (1997).implantation. Targeting of these genes will be key in attrib-
Activation of HER4 by heparin-binding EGF-like growth factoruting their functional signi®cance in uterine biology and
stimulates chemotaxis but not proliferation. EMBO J. 16, 1268±implantation. However, targeting of individual genes in this
1278.
family is unlikely to provide meaningful answers as has Enders, A. C. (1976). Anatomical aspects of implantation. J. Reprod.
been noted for targeting of TGF-a; combinatorial targeting Fertil. 25, 1±15.
of two or more of these genes should provide better under- Enders, A. C., and Schlafke, S. (1967). A morphological analysis of
standing regarding the role of this family of growth factors the early implantation stages in the rat. Am. J. Anat. 120, 185±
in this important female reproductive function. In this re- 226.
Han, J. H., Stratowa, C., and Rutter, W. J. (1987). Isolation of full-spect, mapping of the EGF ligands and their receptors in
length putative rat lysophospholipase cDNA using improvedthe uterus or embryo during the periimplantation period
methods for mRNA isolation and cDNA cloning. Biochemistrywill help in designing appropriate strategies for targeting
26, 1617±1625.these genes in order to de®ne their functions during early
Heldin, C. H. (1995). Dimerization of cell surface receptors in signaldevelopment.
transduction. Cell 80, 213±223.
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brun, M. (1991). A heparin-binding growth factor secreted by
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